Stock Events

Stock Events

Transmedics

$152.35

583

+$2.85+1.91% Friday 20:00

Statistics

Day High

152.47

Day Low

149.17

52W High

154.14

52W Low

36.42

Volume

364,941

Avg. Volume

705,216

Mkt Cap

5.02B

P/E Ratio

-494.96

Dividend Yield

-

Dividend

-

Earnings

30AprConfirmed

Q3 2022

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-0.78

-0.4

-0.03

0.35

Expected EPS

-0.05

Actual EPS

0.35

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TMDX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Medtronic offers a range of medical devices and technologies that can compete with TransMedics' organ transplantation solutions.

Abbott Laboratories

Abbott Laboratories provides a broad portfolio of medical devices, including those for cardiovascular and neuromodulation, which can be seen as indirect competitors to TransMedics' offerings.

Boston Scientific

Boston Scientific Corporation competes in the medical devices sector, offering products that could be used in cardiovascular procedures, potentially competing with TransMedics' organ preservation technologies.

Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products, which could be used in procedures that compete with TransMedics' transplantation solutions.

Edwards Lifesciences

Edwards Lifesciences Corporation focuses on patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, which could indirectly compete with TransMedics' technologies.

Zimmer Biomet Holdings, Inc. offers musculoskeletal healthcare solutions, which could be seen as competing in the broader medical devices market against TransMedics' organ preservation and transplantation technologies.

Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets robotic products for minimally invasive surgery, which could compete with TransMedics in the surgical and transplantation market.

Baxter International

Baxter International Inc. provides a portfolio of healthcare products, including renal and hospital products, which could compete with TransMedics' organ preservation solutions.

Johnson & Johnson

Johnson & Johnson operates in the healthcare field with a broad range of products. Its medical devices segment could indirectly compete with TransMedics in various areas, including surgical technologies.

Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products for women's health, which could compete in the broader healthcare and medical devices market against TransMedics.

Analyst Ratings

130$Average Price Target

The highest estimate is $175.

From 7 ratings within the last 6 months. This is not an investment recommendation.

Buy

86%

Hold

14%

Sell

0%

About

Medical Specialties

Health Technology

Manufacturing

Surgical and Medical Instrument Manufacturing

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Show more...

CEO

Waleed H. Hassanein

Employees

584

Country

US

ISIN

US89377M1099

WKN

000A2PH5P

Listings